- Referring Czech patients with idiopathic pulmonary fibrosis to a transplant center – data from the EMPIRE registry2023 | First Faculty of Medicine, Second Faculty of Medicine
- Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study2022 | First Faculty of Medicine
- The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine
- Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry2019 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine
- EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine
- DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové